Long-term survey of outcome in acute promyelocytic leukemia

Chinese Medical Journal

Volumn 113, Issue 2, 2000, Pages 107-110

  Hu, Jiong ^a   Shen, Zhixiang ^a   Sun, Huiping ^a   Wu, Wen ^a   Li, Xiusong ^a   Sun, Guanlin ^a   Wang, Zhenyi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Arsenic trioxide

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; HYDROXYUREA; MITOXANTRONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; CHILD; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OXIDES; PROGNOSIS; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME; TRETINOIN;

EID: 0343963253     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. De The H, Chomienne C, Lanotte M, et al. The t (15;17) in human acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 1990;347:358-61.
2. Huang ME, Ye YC, Chen SR, et al. Use of all-trans-retinoic acid in the treatment of acute promylocytic leukemia. Blood 1988;72: 567-72.
3. Kaplan EL, Meiyer P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
4. Tallman MS, Anderson JW, Schiffer ScD, et al. All-transretinoic acid in acute promyelocytic leukemia. New Engl J Med 1997; 337:1021-27.
5. Sun GL, Huang YG, Chang XF, et al. All-trans-retinoic acid in the treatment of 544 patients with acute promyelocytic leukemia. Chin J Hematol 1992;13:135.
6. Japan Adult Leukemia Study Group. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J Clin Oncol 1998;16:78-85.
7. 3 induced NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RARα protein. Blood 1996;88:2025.
8. Gianni M, Koken MHM, Chelbi-Alix MK, et al. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. Blood 1998;91:4300-4310.
9. Shao W, Fanelli M, Ferrara FF, et al Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 1998;90:124-133.